Biomarkers in Heart Disease is the first title in the AHA Clinical Series and is aimed at meeting the needs of clinicians, providing cardiologists, internists, emergency physicians, laboratorians, and other healthcare providers with a clear understanding of the role of biomarkers in contemporary cardiovascular medicine.

The book covers both the strengths and pitfalls of currently available markers, and provides information on the most promising biomarkers that are likely to impact practice in the next few years. It is divided into four parts, organized around...

This new title in the American Heart Association Clinical Series offers an up-to-date overview of the causes and damage related to dyssynchronopathy - a new pathophysiological entity related to spontaneous or pacing-induced mechanical abnormalities which causes heart failure. It presents the most recent diagnostic non-invasive tools and provides simple, practice-oriented therapeutic proposals for heart failure patients.